Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes

BMC Medical Research Methodology

Volumn 10, Issue , 2010, Pages

  Lim, Hyun J ^a   Zhang, Xu ^b   Dyck, Roland ^a   Osgood, Nathaniel ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL;

ADULT; CAUSE OF DEATH; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 77958072508     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-10-97     Document Type: Article

References (47)

1. Modelling competing risks in cancer studies. JP Klein, Statistics in Medicine 2006 25 1015 1034 10.1002/sim.2246 16435339
2. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards. J Beyersmann M Dettenkofer H Bertz M Schumacher, Statistics in Medicine 2007 26 5360 5369 10.1002/sim.3006 17634974
3. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. R Agarwal Z Bunaye D Bekele R Light, Amer J of Nephrology 2008 28 569 575 10.1159/000115291 (Pubitemid 351832443)
4. The impact of type 2 diabetes on mortality in end stage renal disease patients differ between genders. A Karame M Labeeuw P Trolliet,, et al. Nephro Clin Pract 2009 112 268 c275 10.1159/000224794
5. A note on competing risks in survival analysis. JM Satagopan L Ben-Porat M Berwick,, et al. Br J Cancer 2004 91 1229 1235 10.1038/sj.bjc.6602102 15305188
6. Nonparametric estimation from incomplete observations. EL Kaplan P Meier, Journal of the American Statistical Association 1958 53 457 481 10.2307/2281868
7. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. JJ Gaynor EJ Feuer CC Tan DH Wu CR Little DJ Straus BD Clarkson MF Brennan, J Am Stat Assoc 2006 88 400 409 10.2307/2290318
8. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data. MS Pepe M Mori, Stat in Medicine 1993 12 737 751 10.1002/sim.4780120803
9. Non-parametric inference for cumulative incidence functions in competing risks studies. DY Lin, Stat in Medicine 1997 16 901 910 10.1002/(SICI)1097- 0258(19970430)16:8<901::AID-SIM5433.0.CO;2-M
10. Kaplan-Meier yielded misleading results in competing risk scenarios. DA Southern PD Faris R Brant PD Galbraith,, et al. J of Clinical Epid 2006 59 1110 1114 10.1016/j.jclinepi.2006.07.002 (Pubitemid 44374316)
11. Analysis of failure times in presence of competing risks. JD Kalbfleisch RL Prentice AV Peterson Jr,, et al. Biometrika 1978 34 541 554
12. JD Kalbfleisch RL Prentice, The statistical analysis of failure time data New York, NY John Wiley & Sons Inc 2 2002
13. Tutorial in Biostatistics: Competing risks and multi-state models. H Putter M Fiocco B Geskus, Statistics in Medicine 2007 26 2389 2430 10.1002/sim.2712 17031868
14. Regression models and life-tables (with discussion). DR Cox, Journal of the Royal Statistical Society B 1972 34 187 220
15. A class of K-sample tests for comparing the cumulative incidence of a competing risk. RJ Gray, Ann Stat 1988 16 1141 1154 10.1214/aos/1176350951
16. A proportional hazards model for the subdistribution of competing risks in survival analysis. JP Fine RJ Gray, J Am Stat Assoc 1999 94 496 509 10.2307/2670170
17. Parametric regression on cumulative incidence function. JH Jung JP Fine, Biostatistics 2007 8 184 196 10.1093/biostatistics/kxj040 16636138
18. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). PC van Dijk KJ Jager B Stengel C Gronhagen-Riska TG Feest JD Briggs, Kidney Int 2005 67 1489 1499 10.1111/j.1523-1755.2005.00227.x 15780102
19. USDRS 2009 Annual Data Report - Atlas of End-Stage Renal Disease in the United States. US Renal Data System, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2009
20. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. VR Sorensen ER Mathiesen J Heaf B Feldt-Rasmussen, Diabetologia 2007 50 922 929 10.1007/s00125-007-0612-5 17333109
21. RG Nelson WC Knowler DJ Pettitt PH Bennett, Kidney disease in diabetes. Diabetes in America Bethesda, MD: National Institutes of Health, Harris MI, 2 1995 Publication no 95-1468
22. Diabetic nephropathy. GC Groggel, Arch Fam Med 1996 5 513 521 10.1001/archfami.5.9.513 8930222
23. Prevention and treatment of diabetic nephropathy. EF Foote, Am J Health-System Pharm 1995 52 1781 1792
24. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). LJ Ubink-Veltmaat HJG Bilo KH Groenier ST Houweling RO Rischen B Meyboom-de Jong, Eur J Epidemiol 2003 18 793 800 10.1023/A:1025369623365 12974556
25. Racial differences in the incidence of end-stage renal disease. GS Tell B Hylander TE Craven J Burkart, Ethn Health 1996 1 21 31 10.1080/13557858.1996. 9961767 9395545
26. Public Health Agency of Canada website, http://www.phac-aspc.gc.ca/cd-mc/ diabetes-diabete/index-eng.php Accessed at Dec. 5, 2009
27. Epidemiology of diabetes mellitus among first Nations and non-first Nations adults. R Dyck N Osgood TH Lin,, et al. CMAJ 2010 [published online Jan 19, 2010] 20083562
28. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. K Gu CC Cowie MI Harris, Diabetes Care 1998 21 1138 1145 10.2337/diacare.21.7.1138 9653609
29. Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991-2005). E Villar SH Chang SP McDonald, Diabetes Care 2007 30 3070 3076 10.2337/dc07-0895 17848610
30. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. GF Salles KV Bloch CR Cardoso, Diabetes Care 2004 27 1299 1305 10.2337/diacare.27.6.1299 15161779
31. ME Levin MA Pfeiffer, The Uncomplicated Guide to Diabetes Complications. American Diabetes Association Alexandria Verginia 1998
32. Natural history of diabetic nephropathy. AS Krolewski JH Warram, Diabetes Rev 1995 3 446 459
33. Diabetic nephropathy: etiologic and therapeutic considerations. RA Defronzo, Diabetes Rev 1995 3 510 564
34. Survival rates of 2,728 patients with end stage renal disease. WL Hellerstedt WJ Hohnson N Ascher,, et al. Mayo Clin Proc 1984 59 776 783 6492873
35. D Collett, Modelling survival data in medical research Capman & Hall/CRC. New York NY 2 2003
36. Applying Cox regression to competing risks. M Lunn N McNeil, Biometrics 1995 51 524 532 10.2307/2532940 7662841
37. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. TA Gooley W Leisenring BE Storere, Statistics in Medicine 1999 18 695 706 10.1002/(SICI)1097-0258(19990330)18: 6<695::AID-SIM603.0.CO;2-O 10204198
38. Misspecified regression model for the subdistribution hazard of a competing risk. A Latouche V Boisson S Chevret R Porcher, Statistics in Medicine 2007 26 965 974 10.1002/sim.2600 16755533
39. Analysing and interpreting competing risk data. M Pintilie, Statistics in Medicine 2007 26 1360 1367 10.1002/sim.2655 16900575
40. Competing risk regression models for epidemiologic data. B Lau SR Cole SJ Gange, Amer J of Epidemiology 2009 26 3676 3679
41. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. BC Tai D Machin I White V Gebski, Statistics in Medicine 2001 20 661 684 10.1002/sim.711 11241570
42. DG Kleinbaum M Klein, Survival Analysis: A self learning Text Springer New York NY 2 2005
43. Summarizing differences in cumulative incidence functions. M Zhang J Fine, Statistics in Medicine 2008 27 4939 4949 10.1002/sim.3339 18563792
44. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. N Grambauer M Schumacher J Beyersmann, Statistics in Medicine 2010 29 875 884 10.1002/sim.3786 20213713
45. Letter to the editor on 'Misspecified regression model for the subdistribution hazard of a competing risk by Latouche A, Boisson V, Chevret S and Porcher R. Statistics in Medicine 2006; DOI: 0.2002/sim.2600'. J Beyersmann M Schumacher, Statistics in Medicine 2007 26 1649 1651 10.1002/sim.2727 17054104
46. On a graphical method for the detection of time-dependent effects of covariate in survival data. J Mau, Applied Statistics 1986 35 24 255 10.2307/2348023
47. Zhang X, Zhang M: SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Computer Methods and Programs in Biomedicine 2010.